Insights into the chemistry and biology of the I-Ag7 class II molecule.

[1]  G. Nepom,et al.  Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions. , 1996, Journal of immunology.

[2]  E. Unanue,et al.  Appreciating the Complexity of MHC Class II Peptide Binding: Lysozyme Peptide and I‐Ak , 1996, Immunological reviews.

[3]  D. Fremont,et al.  Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.

[4]  C. Fathman,et al.  Breaking self-tolerance in nonobese diabetic mice , 1996, The Journal of experimental medicine.

[5]  E. Unanue,et al.  The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. , 1996, Journal of immunology.

[6]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[7]  L. Chuang.  Immunogenetics and IDDM , 1994 .

[8]  S. Tonegawa,et al.  A differential-avidity model for T-cell selection. , 1994, Immunology today.

[9]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[10]  C. Janeway,et al.  Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. , 1994, Journal of immunology.

[11]  E. Thorsby,et al.  Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(α1*0501, β1*0201) molecule , 1994 .

[12]  D. Wraith,et al.  An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. , 1993, International immunology.

[13]  E. Unanue,et al.  Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. , 1993, Journal of immunology.

[14]  L. Adorini,et al.  Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide , 1993, The Journal of experimental medicine.

[15]  E. Unanue,et al.  Identification of two distinct properties of class II major histocompatibility complex-associated peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[17]  E. Unanue,et al.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[19]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[20]  R. Germain,et al.  A role for peptide in determining MHC class II structure , 1991, Nature.

[21]  I. Cohen,et al.  Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Houghten,et al.  Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction. , 1989, Journal of immunology.

[23]  J. Todd,et al.  HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.

[24]  H. Mcdevitt,et al.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Dorf,et al.  The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. , 1986, Science.

[26]  P. Morris,et al.  A Method for Isolation of Islets of Langerhans from the Human Pancreas , 1984, Diabetes.

[27]  E. Unanue,et al.  Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. , 1981, Journal of immunology.

[28]  E. Unanue,et al.  Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope , 1987, Nature.

[29]  E. Unanue,et al.  Binding of immunogenic peptides to Ia histocompatibility molecules , 1985, Nature.

[30]  E. Unanue,et al.  Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.